Ontology highlight
ABSTRACT: Rationale
Refractory nasopharyngeal carcinoma is challenging to treat and at present there is no standard treatment or any good choice.Patient concerns
Although the three patients in our case reports had already underwent multiple treatments before, they still suffered from disease recurrence of nasopharyngeal carcinoma.Diagnosis
They were diagnosed as refractory nasopharyngeal carcinoma.Interventions
A continuous infusion of Endostar, an antiangiogenic agent, combined with chemotherapy and radiation therapy was given to treat the patients.Outcomes
Patients showed complete or partial response to the combined therapy as evidenced by regression of tumors and decrease in plasma Epstein-Barr virus (EBV) DNA load.Lessons
Continuous infusions of En
SUBMITTER: Chen C
PROVIDER: S-EPMC6709293 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature